Influenza B virus (strain B/Malaysia/2506/04)

Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Malaysia/2506/04.

Serological studies of influenza B virus, immunogen for antibody production.

Purity > 90 %

Ultracentrifugation with 10 – 40 % sucrose gradient.

STE, 0.09 % sodium azide (NaN3) and 0.005 % thimerosal.

-20 °C (between -15 and -30 °C allowed)

Thimerosal and beta propiolactone treatment.
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.

This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.
Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.

Influenza and Other Acute Respiratory Diseases (ARDs) Assay Notes

Search Influenza B virus-4 references from PubMud.

See all influenza references.

See other infectious diseases and veterinary reagents.